By expenditures
| Name | Title | Type |
|---|---|---|
| Amanda Eaves | Partner | Auditee |
| Nachum Golodner | Director of Accounting | Auditee |
| Kurt Schlicker | Senior Audit Associate | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 345431 | 2024 | 2025-03-10 | Forvis Mazars LLP | $1.20M |
| 295695 | 2023 | 2024-03-18 | Forvis | $1.66M |
| 43510 | 2022 | 2023-07-30 | Eide Bailly LLP | $973,862 |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 345431 | 2024 | 2025-03-10 | 1102955 | 2024-001 | Material Weakness | - | I |
| 345431 | 2024 | 2025-03-10 | 526513 | 2024-001 | Material Weakness | - | I |
| 295695 | 2023 | 2024-03-18 | 957408 | 2023-008 | Material Weakness | - | L |
| 295695 | 2023 | 2024-03-18 | 957407 | 2023-008 | Material Weakness | - | L |
| 295695 | 2023 | 2024-03-18 | 957406 | 2023-007 | Material Weakness | Yes | I |
| 295695 | 2023 | 2024-03-18 | 957405 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 957404 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 957403 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 957402 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 957401 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 957400 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 957399 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 957398 | 2023-005 | Material Weakness | Yes | AB |
| 295695 | 2023 | 2024-03-18 | 380966 | 2023-008 | Material Weakness | - | L |
| 295695 | 2023 | 2024-03-18 | 380965 | 2023-008 | Material Weakness | - | L |
| 295695 | 2023 | 2024-03-18 | 380964 | 2023-007 | Material Weakness | Yes | I |
| 295695 | 2023 | 2024-03-18 | 380963 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 380962 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 380961 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 380960 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 380959 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 380958 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 380957 | 2023-006 | Significant Deficiency | - | AB |
| 295695 | 2023 | 2024-03-18 | 380956 | 2023-005 | Material Weakness | Yes | AB |
| 43510 | 2022 | 2023-07-30 | 626172 | 2022-013 | Material Weakness | - | P |
| 43510 | 2022 | 2023-07-30 | 626171 | 2022-012 | Material Weakness | - | I |
| 43510 | 2022 | 2023-07-30 | 626170 | 2022-011 | Material Weakness | - | AB |
| 43510 | 2022 | 2023-07-30 | 49730 | 2022-013 | Material Weakness | - | P |
| 43510 | 2022 | 2023-07-30 | 49729 | 2022-012 | Material Weakness | - | I |
| 43510 | 2022 | 2023-07-30 | 49728 | 2022-011 | Material Weakness | - | AB |